Milgamma Neuro (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine is a lipid‑soluble thiamine derivative that readily enters cells and is converted to thiamine diphosphate. This co‑factor enhances glucose metabolism, reduces harmful advanced glycation end‑products, and protects nerve cells from metabolic stress.

The appropriate dose of Milgamma Neuro is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Pregnant or breastfeeding individuals should only use Milgamma Neuro after consulting a qualified healthcare provider. The benefits and potential risks need to be evaluated on a case‑by‑case basis.

To order Milgamma Neuro, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and necessary import documentation.

Milgamma Neuro uniquely combines benfotiamine, a thiamine pro‑drug with strong metabolic effects, and pyridoxine, a vitamin B6 source essential for neurotransmitter synthesis. Many single‑vitamin products lack this dual mechanism, making Milgamma Neuro a more comprehensive option for addressing both thiamine‑ and pyridoxine‑related nerve concerns.

Store Milgamma Neuro at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the package is tightly closed to maintain product stability.

Milgamma Neuro is taken orally, usually with water. The exact timing (e.g., with meals or on an empty stomach) should follow the prescribing clinician’s guidance to optimize absorption and minimize gastrointestinal discomfort.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, significant liver enzyme elevations indicating possible hepatic injury, and, in very uncommon cases, worsening of neuropathic symptoms. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, jaundice, or rapid symptom progression.

Individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the tablet should avoid Milgamma Neuro. Those with severe liver or kidney disease, or who are taking medications that may interact adversely, should only use it under close medical supervision.